Low rates of headache and migraine associated with intravenous immunoglobulin infusion using a 15-minute rate escalation protocol in 123 patients with primary immunodeficiency

INTRODUCTION: Headache and migraine adverse events are common concerns in the administration of intravenous immune globulins (IVIG). Trials of IVIG for primary immunodeficiency (PI) are typically small and have reported headache and migraine data inconsistently. METHODS: We analyzed headache and mig...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Bob, Clark, Kim, Evangelista, Mark, Wolford, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932595/
https://www.ncbi.nlm.nih.gov/pubmed/36818468
http://dx.doi.org/10.3389/fimmu.2022.1075527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932595/
https://www.ncbi.nlm.nih.gov/pubmed/36818468
http://dx.doi.org/10.3389/fimmu.2022.1075527

Ejemplares similares